Compugen Company Profile (NASDAQ:CGEN)

Analyst Ratings

Consensus Ratings for Compugen (NASDAQ:CGEN) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.67 (77.04% upside)

Analysts' Ratings History for Compugen (NASDAQ:CGEN)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$14.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$14.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingBuy$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015MLV & Co.Reiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Compugen (NASDAQ:CGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/9/2016Q415($0.11)($0.01)$3.33 million$8.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.15)($0.13)$1.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.14)($0.14)$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.13)($0.12)$1.48 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414($0.11)($0.03)$3.70 million$6.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314($0.11)($0.11)$1.90 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.11)($0.05)$1.85 million$2.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/19/2014Q114($0.10)($0.04)$0.16 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413($0.09)$0.13 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.12)$0.11 million$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Compugen (NASDAQ:CGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.15)($0.13)($0.14)
Q2 20161($0.17)($0.17)($0.17)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Compugen (NASDAQ:CGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Compugen (NASDAQ:CGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Compugen (NASDAQ:CGEN)
DateHeadline
07/21/16 06:32 AMEarnings Focus and Crowd Sourced Sentiment Review for Compugen Ltd. (NASDAQ:CGEN) - TGP
07/21/16 06:32 AMWere Analysts Bullish Compugen Ltd. (USA) (NASDAQ:CGEN) This Week? - Consumer Eagle
07/21/16 06:00 AMCompugen Second Quarter 2016 Conference Call Scheduled for Tuesday, August 2, 2016 at 10:00 AM ET - [PR Newswire] - HOLON, Israel, July 21, 2016 /PRNewswire/ -- Compugen Ltd. ( NASDAQ: CGEN ), a leading predictive drug discovery company, today announced that the Company will host a conference call at 10:00 AM ET on ...
07/20/16 11:13 AMCompugen Ltd. (NASDAQ:CGEN): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/18/16 08:12 AMTrading Performance and Target Watch for Compugen Ltd. (NASDAQ:CGEN) - Press Telegraph
07/17/16 07:49 AMCompugen Limited (NASDAQ:CGEN) Shorted Shares Decreased By 11.99% - Press Telegraph
07/17/16 07:49 AMNew Broker Ratings For Compugen Ltd. (CGEN) - FTSE News
07/12/16 08:37 PMAnalyst Target and Average Rating Watch: Compugen Ltd. (NASDAQ:CGEN) - Press Telegraph
07/08/16 07:26 AMCompugen Ltd. breached its 50 day moving average in a Bearish Manner : CGEN-US : July 8, 2016 -
07/07/16 03:13 PMWall Street Ratings and Target Price Views on Compugen Ltd. (NASDAQ:CGEN) - Telanagana Press
07/06/16 07:56 AMBroker Outlook For Compugen Ltd. (CGEN) - Fiscal Standard
07/05/16 07:56 AMCompugen Ltd. (CGEN) Broker Price Targets For The Coming Week - Fiscal Standard
06/30/16 10:59 AMCompugen Ltd. (CGEN) Current Analyst Ratings - Fiscal Standard
06/28/16 02:31 PMCompugen Ltd. (NASDAQ:CGEN) Earnings Glance and Target Price Review - Engelwood Daily
06/28/16 02:31 PMEquity Research and Technical Review on Compugen Ltd. (NASDAQ:CGEN) - Press Telegraph
06/28/16 02:31 PMBroker Outlook For The Week Ahead Compugen Ltd. (CGEN) - Fiscal Standard
06/28/16 02:31 PMShare Update and Earnings Review for Compugen Ltd. (NASDAQ:CGEN) - Press Telegraph
06/22/16 08:29 PMForm 6-K COMPUGEN LTD For: Jun 22
06/22/16 03:20 PMCompugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 ... - Benzinga
06/22/16 09:00 AMCompugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 Anticipated in 2017 -
06/22/16 07:08 AMCompugen Ltd. breached its 50 day moving average in a Bullish Manner : CGEN-US : June 22, 2016 -
06/22/16 06:39 AMCompugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program - [at noodls] - bedafc9a-6240-40c0-84a2-305f207c3622.pdf FOR IMMEDIATE RELEASE IND filing for COM701 anticipated next year Holon, Israel - June 22, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive therapeutic ...
06/19/16 03:02 PMWill Compugen Ltd. (NASDAQ:CGEN) Surprise This Quarter? - Investor Newswire
06/19/16 03:02 PMThis Weeks Broker Views For Compugen Ltd. (CGEN) - Fiscal Standard
06/15/16 06:39 AMCompugen to Present at JMP Securities Life Sciences Conference in New York - [at noodls] - 3f544505-39b9-43ba-b7a7-b58258e514bb.pdf FOR IMMEDIATE RELEASE Holon, Israel - June 15, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
06/10/16 07:20 AMCompugen Ltd. breached its 50 day moving average in a Bearish Manner : CGEN-US : June 10, 2016 -
06/06/16 07:30 AMBrokers Issue Forecasts for Compugen Ltd.'s FY2017 Earnings (CGEN) - Let Me Know About This
06/03/16 09:16 PMCompugen Ltd. (NASDAQ:CGEN) Stock Update & Estimates - Stock Tick Tock
06/01/16 09:20 PMCompugen Limited (NASDAQ:CGEN) Shorted Shares Increased By 0.37% - HNN - Compugen Limited (NASDAQ:CGEN) Shorted Shares Increased By 0.37%HNNThe stock of Compugen Limited (NASDAQ:CGEN) registered an increase of 0.37% in short interest. CGEN's total short interest was 1.60M shares in June as published by FINRA. Its up 0.37% from 1.59 million shares, reported previously. With 128,900 shares ...
05/31/16 08:37 AMTarget Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN) - HNN - Target Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN)HNNTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Compugen Ltd.and more »
05/31/16 08:37 AMStock Review and Earnings Check on Compugen Ltd. (NASDAQ:CGEN) - HNN - Stock Review and Earnings Check on Compugen Ltd. (NASDAQ:CGEN)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Compugen Ltd. (NASDAQ:CGEN) ...and more »
05/30/16 10:04 AMNext Weeks Broker Price Targets For Compugen Ltd. (CGEN) - Share Trading News - Next Weeks Broker Price Targets For Compugen Ltd. (CGEN)Share Trading NewsCompugen Ltd. has a 50 day moving average of 6.77 and a 200 day moving average of 6.10. The stock's market capitalization is 345.78M, it has a 52-week low of 4.32 and a 52-week high of 7.98. The share price of the company (CGEN) was up +0.15%, with ...and more »
05/27/16 06:47 PMCompugen Ltd. (CGEN) Updated Price Targets - FTSE News - Compugen Ltd. (CGEN) Updated Price TargetsFTSE NewsCompugen Ltd. has a 50 day moving average of 6.77 and a 200 day moving average of 6.10. The stock's market capitalization is 345.27M, it has a 52-week low of 4.32 and a 52-week high of 7.98. The share price of the company (CGEN) was down -2.57%, ...and more »
05/26/16 05:00 AM'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway -
05/25/16 06:28 PMStock Rating Review for Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Stock Rating Review for Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1 on shares of Compugen Ltd. (NASDAQ:CGEN). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is ...and more »
05/25/16 06:28 PMCompugen Ltd. (NASDAQ:CGEN) Impact Score At 100 - Stocks Daily - Compugen Ltd. (NASDAQ:CGEN) Impact Score At 100Stocks DailyAlpha One explored various online articles released on Compugen Ltd. (NASDAQ:CGEN), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued on ...and more »
05/24/16 10:29 AMEarnings Review and Stock Rundown for Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Earnings Review and Stock Rundown for Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Compugen Ltd. (NASDAQ:CGEN) to post ...and more »
05/23/16 06:31 PMTarget Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN) - Wall Street Hints and News - Target Check and Stock Performance Recap Compugen Ltd. (NASDAQ:CGEN)Wall Street Hints and NewsIn recent session activity, Compugen Ltd. (NASDAQ:CGEN) shares have traded +0.88%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has been recorded ...and more »
05/23/16 03:55 PMETF’s with exposure to Compugen Ltd. : May 23, 2016 -
05/23/16 06:16 AMCompugen to Present at the Jefferies Global Healthcare Conference in New York - [at noodls] - 8c7f6c0e-dbd3-4dba-92d0-c92220c7f618.pdf FOR IMMEDIATE RELEASE Holon, Israel - May 23, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
05/22/16 11:14 AMCompugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $0.421 - RealistInvestor.com - Compugen Ltd. (NASDAQ:CGEN) Comprehensive Income At $0.421RealistInvestor.comFor the year ended 2015-12-31, Compugen Ltd. (NASDAQ:CGEN)comprehensive income was $0.421 millions whereas for the quarter ended 2015-12-31, it was $0.421 millions. Compugen Ltd. (NASDAQ:CGEN) posted $-20.163 millions on combined net ...
05/20/16 11:36 PMRevenue Update on Compugen Ltd. (USA)(NASDAQ:CGEN) - Trade Calls - Revenue Update on Compugen Ltd. (USA)(NASDAQ:CGEN)Trade CallsCompugen Ltd. (USA)(NASDAQ:CGEN) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Company reported revenue of $93.00K. Analysts estimated a revenue of $640.00K. Earnings per ...Compugen Ltd. (CGEN) Updated Broker Price TargetsShare Trading NewsCompugen Limited (NASDAQ:CGEN) Shorted Shares Decreased By 7.82%Franklin IndependentMorning Buzz: Compugen Ltd. (NASDAQ:CGEN), Trio-Tech International (NYSEMKT:TRT), Lantronix, Inc. (NASDAQ ...Benchmark Monitorall 4 news articles »
05/18/16 10:50 AMBroker Roundup For Compugen Ltd. (CGEN) - Share Trading News - Broker Roundup For Compugen Ltd. (CGEN)Share Trading News08/05/2015 – Compugen Ltd. had its “buy” rating reiterated by analysts at MLV & Co. They now have a USD 14 price target on the stock. 05/06/2015 – Compugen Ltd. was downgraded to “sell” by analysts at Zacks. The share price of Compugen Ltd. (CGEN) ...and more »
05/16/16 07:42 AMCompugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv - [at noodls] - 6594cb84-c2a4-41f0-b4cd-37be5fe21955.pdf FOR IMMEDIATE RELEASE Holon, Israel - May 16, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, ...
05/16/16 03:01 AMCompugen Ltd. :CGEN-IL: Earnings Analysis: Q1, 2016 By the Numbers : May 16, 2016 -
05/12/16 11:24 AMCompugen Ltd. :CGEN-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 06:51 PMCompugen : Steven Holtzman Joins Compugen as Strategic Business Advisor - Compugen Ltd. (NASDAQ: CGEN [http://finance.yahoo.com/q?s=cgen ]), a leading predictive drug discovery company, announced today that Steven Holtzman, former Executive Vice President, Corporate Development of Biogen, has joined Compugen as a strategic ...
05/10/16 07:48 AMCompugen Ltd. Reports First Quarter 2016 Financial Results - [at noodls] - c69efef6-7723-4587-88ba-4a9f681c1cf3.pdf FOR IMMEDIATE RELEASE Holon, Israel, May 10, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results ...
05/10/16 06:14 AMCompugen reports 1Q loss -
04/07/16 01:48 PMDr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. - [at noodls] - 4a2e27db-8bf5-49c3-8338-caeaf21c23a6.pdf For Immediate Release Holon, Israel - April 6, 2016 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced today that Elliott Sigal, ...

Social

About Compugen

Compugen logoCompugen Ltd. (Compugen) is a therapeutic discovery company. The Company focuses on the discovery and development of monoclonal antibodies (mAbs) and therapeutic proteins in the fields of oncology and immunology. Its pipeline program consists of drug targets and therapeutic product candidates at various stages ranging from target validation to pre-clinical studies in the fields of oncology and immunology, with a primary focus on immuno-oncology. The Company's therapeutic proteins for immunology include CGEN-15001T, CGEN-15022, CGEN-15029, CGEN-15049 and CGEN-15092, which are based on B7/CD28-like immune checkpoint candidates. It offers various infrastructure platforms, which include LEADS, MED and LINKS, which integrates its scientific understandings and predictive models. It offers various target discovery platforms, which include Antibody-Drug Conjugate Cancer Therapy Discovery Platform, Other Discovery Approaches for Immunomodulatory Proteins and Biomarker Discovery Approaches.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGEN
  • CUSIP:
Key Metrics:
  • Previous Close: $6.59
  • 50 Day Moving Average: $6.62
  • 200 Day Moving Average: $6.03
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $333.63M
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $-0.67 EPS
  • Next Year EPS Consensus Estimate: $-0.57 EPS
Additional Links:
Compugen (NASDAQ:CGEN) Chart for Monday, July, 25, 2016